These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9949685)

  • 1. Regulation of estrogen action: role of 17 beta-hydroxysteroid dehydrogenases.
    Peltoketo H; Vihko P; Vihko R
    Vitam Horm; 1999; 55():353-98. PubMed ID: 9949685
    [No Abstract]   [Full Text] [Related]  

  • 2. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.
    Ito K; Utsunomiya H; Suzuki T; Saitou S; Akahira J; Okamura K; Yaegashi N; Sasano H
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):136-40. PubMed ID: 16406263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
    Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
    Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of oestrogen action: role of 17 beta-hydroxysteroid dehydrogenases.
    Poutanen M; Isomaa V; Peltoketo H; Vihko R
    Ann Med; 1995 Dec; 27(6):675-82. PubMed ID: 8652148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
    Smuc T; Rizner TL
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes as modulators in malignant transformation.
    Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
    Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
    Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 17 beta-hydroxysteroid dehydrogenases.
    Mindnich R; Möller G; Adamski J
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):7-20. PubMed ID: 15130507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 17beta-hydroxysteroid dehydrogenase type 4 in human ovarian surface epithelial cells.
    Nagayoshi Y; Ohba T; Yamamoto H; Miyahara Y; Tashiro H; Katabuchi H; Okamura H
    Mol Hum Reprod; 2005 Sep; 11(9):615-21. PubMed ID: 16219629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
    Aka JA; Mazumdar M; Lin SX
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1, 2, 5 and 7 mRNAs in human early and mid-gestation placentas.
    Li Y; Isomaa V; Pulkka A; Herva R; Peltoketo H; Vihko P
    Placenta; 2005 May; 26(5):387-92. PubMed ID: 15850643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen metabolizing enzymes in endometrium and endometriosis.
    Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
    Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
    Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.
    Rizner TL; Smuc T; Rupreht R; Sinkovec J; Penning TM
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):126-35. PubMed ID: 16338060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.